Lumbar Spine Degeneration
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
MedtronicINFUSE Bone Graft
3SpineMOTUS Total Joint Replacement
3SpineLumbar Interbody Fusion
Clinical Trials (3)
Total enrollment: 349 patients across 3 trials
INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine
Start: Jul 2011Est. completion: Jan 201515 patients
Phase 3Terminated
MOTUS Total Joint Replacement Investigational Device Exemption Study
Start: Jun 2022Est. completion: Jun 2029158 patients
N/AActive Not Recruiting
3Spine Lumbar Fusion Real World Evidence Study
Start: May 2021Est. completion: Nov 2029176 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.